The European Commission has granted marketing authorization for Eylea 8mg (aflibercept 8mg, 114.3mg/ml solution for injection ...
Advances in device technologies and component innovations, such as Datwyler’s NeoFlex™ plungers, facilitate home-based ...
Three firms receive favourable recommendation from SEC on semaglutide formulations: Gireesh Babu, New Delhi Monday, January 19, 2026, 08:00 Hrs [IST] With the patent for Danish dr ...
suitable for safely storing and administering highly sensitive biologics, including cell and gene therapies, biosimilars, and ...
The collaboration between ten23 health and BD aims to commercialize the BD Libertas wearable injector for large-volume ...
European Commission grants marketing approval for Eylea 8 mg to treat macular edema following RVO, including branch, central and hemiretinal vein occlusion: Berlin Monday, January ...
The Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) has recommended grant of ...
Aseptic processing demands reliable, robust, and validated analytical methods to ensure sterility, safety, and quality, ...
Contract manufacturer introduces injection device featuring adjustable parameters and streamlined assembly process.
MGS, a provider of end-to-end healthcare solutions, has launched the A.i.r. Platform, a customizable auto-injector platform ...
At Pharmapack, TekniPlex Healthcare to Unveil Expanded Multidose Packaging Capabilities and Advanced Barrier Materials for ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback